These stocks are likely to be in focus on February 3

These stocks are likely to be in focus on February 3

by 5paisa Research Team Last Updated: 2022-02-02T17:32:01+05:30

At market close on Wednesday, the core equity indices, Sensex and Nifty ended up more than 1% on the upside. The Sensex was at 59,558.33, up by 695.76 points or 1.18% and the Nifty was at 17,780, up by 203.15 points or 1.16%.

These stocks are likely to be in focus for Wednesday's trading session

Alembic Pharma Limited:  Alembic Pharmaceuticals has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Fesoterodine Fumarate Extended-Release Tablets, 4 mg and 8 mg. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Toviaz Extended-Release Tablets, 4 mg and 8 mg, of Pfizer Inc. Fesoterodine Fumarate Extended-Release Tablets, are indicated for the treatment of overactive bladder (OAB) in adults with symptoms of urge urinary incontinence, urgency, and frequency. Fesoterodine Fumarate Extended-Release Tablets, 4 mg and 8 mg have an estimated market size of US$ 225 million for twelve months ending September 2021, according to IQVIA. The company’s stock was at Rs 772.30, up by 1.33% on the BSE.

Jubilant FoodWorks Limited: Jubilant FoodWorks reported a growth of 9.8% in net profit to Rs 1,373 crore as revenue from operations rose by 12.9% to Rs 11,935 crore in Q3 FY22 over Q3 FY21. EBITDA in Q3 FY22 was Rs 3,174 crore, up by 13.9% from Rs 2,786 crore in Q3 FY21. EBITDA margin was 26.6% in Q3 FY22 against 26.4% in Q3 FY21. The quarter also saw record new store openings with a landmark 75 new Domino's stores being opened. The company forayed into 17 new cities during the quarter, it now reaches a total of 322 cities across India. The scrip was down by 4.04% at Rs 3301.25, at market close.

Housing Development Finance Corporation Limited: HDFC Ltd reported a profit after tax of Rs 3,261 crore in Q3FY22 compared to Rs 2,926 crore in the corresponding quarter of the previous year, posting a growth of 11% Y-o-Y. The total revenue from operations of the company came at Rs 11783 crore in the October-December quarter as against Rs 11707 crore in a year-ago quarter, up by 0.60% Y-o-Y. The gross non-performing assets came at 2.32% from 2 quarter-on-quarter. The stock of the lending company was up by 1.87% at Rs 2612 per share on BSE.

52-week high stocks – From the BSE 200 pack, the stocks of Canara Bank, AU Small Finance Bank, Bank of Baroda, and Sun Pharmaceuticals also have hit their 52-week high on Wednesday.

Start Investing in 5 mins*

Get Benefits worth 2100* | Rs. 20 Flat Per Order | 0% Brokerage

About the Author

Our research team is composed of some highly qualified research professionals, their expertise range across sectors.

Open Free Demat Account

& get benefits worth 2100*

Resend OTP
Please Enter OTP
  • Have Promo code?
  • Use code ACT2100
Enter Promo code

By proceeding, you agree to the T&C.

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number